DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Wagner K, Wong B, Byrne B. , et al.
A randomized, placebo-controlled, double-blind, Phase 1b/2 study of the novel antimyostatin adnectin RG6206 (BMS-986089) in ambulatory boys with Duchenne muscular dystrophy (P5.431).
Neurology 2018;
90 (15) 5
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.